In view of the remarkable systemic symptoms associated with aortitis, which can be misdiagnosed as infection in neutropenic patients undergoing chemotherapy, clinicians should be aware of aortitis as a possible complication of G-CSF therapy, especially in breast cancer patients treated with PEGylated filgrastim. Here, CSF3 is linked to breast carcinoma.